Delivery Order SPE2DB22D1103-SPE2DB24FTFH1
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor subsidiary of Amerisourcebergen Corporation, for the supply of VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a potential value of $1,113.28 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this specific award. This order is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product called VIMPAT 10 MG/ML SOLUTION 200ML. The contract, valued at $1,292.15, has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a ceiling value of $1,172.13 and a period of performance through June 10, 2025. The contract is not set aside and was awarded on a competitive basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 200ml bottles of the pharmaceutical product VIMPAT 10 MG/ML Solution. The contract has a completion date of January 22, 2024 and a potential value of $1,604.36. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,279.00 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of VIMPAT 10 mg/mL solution in 200mL quantities. This is a firm fixed price, non-set-aside contract with a completion date of June 6, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide VIMPAT 100 MG TABLET 60S pharmaceutical products. The $2,384.84 contract has a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200 ml quantities, with a ceiling value of $1,048.32. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, awarded on September 3, 2025. The award carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- This federal contract award is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML pharmaceutical products to the Defense Logistics Agency (DLA), a major defense agency within the U.S. Department of Defense (DoD). The contract, valued at $1,207.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a Firm Fixed Price basis. The contract has a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,662.52 firm fixed-price delivery order is for the supply of VIMPAT 10 MG/ML SOLUTION 200ML, a specialty medication. The contract has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a $1,705.70 firm fixed price delivery order contract to provide VIMPAT 100 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFH1Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a completion date of February 16, 2024 and a potential value of $1,688.80. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not associated with any set-aside designations. The contract is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/15/24 |